LITHOSTAT Drug Patent Profile
When do Lithostat patents expire, and what generic alternatives are available?
Lithostat is a drug marketed by Mission Pharma and is included in one NDA.
The generic ingredient in LITHOSTAT is acetohydroxamic acid. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the acetohydroxamic acid profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LITHOSTAT?
- What are the global sales for LITHOSTAT?
- What is Average Wholesale Price for LITHOSTAT?
Summary for LITHOSTAT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 143 |
| Clinical Trials: | 2 |
| Patent Applications: | 2,639 |
| Drug Prices: | Drug price information for LITHOSTAT |
| What excipients (inactive ingredients) are in LITHOSTAT? | LITHOSTAT excipients list |
| DailyMed Link: | LITHOSTAT at DailyMed |
Recent Clinical Trials for LITHOSTAT
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Data Management and Coordinating Center (DMCC) | Phase 1/Phase 2 |
| Children's Hospital of Philadelphia | Phase 1/Phase 2 |
| Nicholas Ah Mew | Phase 1/Phase 2 |
Pharmacology for LITHOSTAT
| Drug Class | Urease Inhibitor |
| Mechanism of Action | Urease Inhibitors |
US Patents and Regulatory Information for LITHOSTAT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mission Pharma | LITHOSTAT | acetohydroxamic acid | TABLET;ORAL | 018749-001 | May 31, 1983 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
